Has Warren Lichliter, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,888 in general payments to Warren Lichliter, MD across 538 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Warren Lichliter, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Warren Lichliter, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Warren Lichliter, MD

Colon & Rectal Surgery · Dallas, TXNPI 1639249253

Payments from drug & device makers

$10,888in general payments, 2019–2025

Across 538 payments — averaging $20.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Takeda Pharmaceuticals U.S.A., Inc.$3K
AbbVie$2K
Merck$599
Organon$527
Johnson & Johnson$510
Medtronic$373
plus $4K from 41 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Takeda Pharmaceuticals U.S.A., Inc.	120	$2,849
AbbVie(2 entities)	129	$2,395
Merck	38	$599
Organon	43	$527
Johnson & Johnson(2 entities)	24	$510
Medtronic(2 entities)	13	$373
Stryker	4	$355
Lilly USA, LLC	11	$257
Pfizer	13	$252
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	14	$248
Aimmune Therapeutics, Inc.	13	$236
TELA Bio, Inc.	10	$191
Braintree Laboratories, Inc.	11	$166
Shire North American Group Inc	13	$166
Mallinckrodt Enterprises LLC	10	$164
Axonics, Inc.	8	$154
THD America, Inc.	2	$133
Tetraphase Pharmaceuticals, Inc.	12	$118
Hollister Incorporated	1	$115
Medical Device Business Services, Inc.	1	$112
Kerecis Limited	2	$100
Dilon Technologies, Inc.	2	$97
Mallinckrodt Hospital Products Inc.	5	$78
Cumberland Pharmaceuticals, Inc.	3	$57
Amgen	2	$54
Activ Surgical, Inc.	1	$54
Integra Lifesciences Corporation	3	$48
Boehringer Ingelheim	2	$44
Heron Therapeutics, Inc.	2	$42
Innovation Technologies Inc	2	$41
AstraZeneca	2	$40
Acell, Inc.	3	$39
KCI USA, Inc.	2	$32
Prescient Surgical	2	$30
Covidien LP	2	$27
Avanos Medical	1	$22
Intercept Pharmaceuticals, Inc.	1	$21
Celltrion USA Inc.	1	$21
Baxter Healthcare	1	$20
Biom'up SA	1	$16
W. L. Gore & Associates, Inc.	1	$15
Acacia Pharma Inc	1	$15
Nestle Healthcare Nutrition Inc.	1	$13
Convatec Inc.	1	$12
Pacira Pharmaceuticals Incorporated	1	$12
Endo Pharmaceuticals Inc.	1	$11
QOL Medical, LLC	2	$4

How this compares

$10,888 in reported general payments places this provider in the 70th percentile of 200 colon & rectal surgery providers in Texas.

See all colon & rectal surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$135,496

Medicare patients

327

Services billed

709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other colon & rectal surgery in Dallas

Katerina WellsDallas$182K
Robert JacobsonDallas$125K
Anand LodhaDallas$40K
Roberto Rodriguez-RuesgaDallas$38K
Michael PendolaDallas$21K
Anthony MacalusoDallas$20K
Sarah StringfieldDallas$19K
Zachary RobertsDallas$17K
Edward FrankoDallas$13K
Lai XueDallas$13K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →